Lorenza Rimassa
洛伦扎·里马萨
MD
Associate Professor of Medical Oncology肿瘤内科学副教授
👥Biography 个人简介
Lorenza Rimassa is a leading Italian expert in HCC and biliary tract cancers, with major contributions to immunotherapy combinations and second-line systemic therapy trials. She is a principal investigator in key European HCC and cholangiocarcinoma studies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
HCC Immunotherapy Combinations
Investigated novel immunotherapy-based combinations for advanced HCC, contributing clinical and translational insights to emerging combination regimens.
Biliary Tract Cancer Research
Conducted pivotal research into systemic therapies for cholangiocarcinoma and gallbladder cancer, advancing FGFR inhibitor and immunotherapy trials.
Second-line HCC Therapy
Contributed to defining second-line standards after sorafenib progression through investigator roles in regorafenib and other agent trials.
Representative Works 代表性著作
Tivantinib for second-line treatment of MET-high HCC (METIV-HCC)
Lancet Oncology (2018)
Key biomarker-driven phase III trial informing MET pathway targeting strategies and study design in HCC.
Systemic therapy for biliary tract cancer: a review of clinical practice
Annals of Oncology (2022)
Comprehensive review integrating new molecular targets and immunotherapy data into biliary cancer management.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Zev Wainberg
UCLA Health / David Geffen School of Medicine
Cathy Eng
Vanderbilt-Ingram Cancer Center
Daniel Coit
Memorial Sloan Kettering Cancer Center
Johanna Bendell
Sarah Cannon Research Institute
关注 洛伦扎·里马萨 的研究动态
Follow Lorenza Rimassa's research updates
留下邮箱，当我们发布与 Lorenza Rimassa（Humanitas University and IRCCS Humanitas Research Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment